Chronic rhinosinusitis and recurrent nasal polyps in two children with IgG subclass deficiency and review of the literature

Journal of the Medical Association of Thailand

Volumn 88, Issue SUPPL. 8, 2005, Pages

  Chinratanapisit, Sasawan ^a   Tunsuriyawong, Prayuth ^a   Vichyanond, Pakit ^a   Visitsunthorn, Nualanong ^a   Luangwedchakarn, Voravich ^a   Jirapongsananuruk, Orathai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chronic rhinosinusitis; Immune deficiency; Immunoglobulin subclass; IVIG; Nasal polyps

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CETIRIZINE; CLINDAMYCIN; CORTICOSTEROID; DECONGESTIVE AGENT; GENTAMICIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; ITRACONAZOLE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MOMETASONE FUROATE; MONTELUKAST; PREDNISOLONE;

ADENOIDECTOMY; ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CHRONIC SINUSITIS; CLINICAL FEATURE; DRUG DOSE REDUCTION; ENDOSCOPIC SURGERY; ETHMOIDECTOMY; FOLLOW UP; HUMAN; IMMUNOGLOBULIN G DEFICIENCY; LABORATORY TEST; LAVAGE; MALE; NOSE POLYP; NOSE SURGERY; PATIENT REFERRAL; POLYPECTOMY; RECURRENT DISEASE; RHINOSINUSITIS;

CHILD; ENDOSCOPY; HUMANS; IGG DEFICIENCY; MALE; NASAL MUCOSA; NASAL POLYPS; RECURRENCE; RHINITIS; SINUSITIS;

EID: 31744435649     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bachert C, Cauwenberge PV. Nasal polyps and sinusitis. In: Adkinson NF Jr, Yungginger JW, Busse WW, et al, eds. Allergy Principles and Practice. Philadelphia: Mosby Inc, 2003:1421-36.
2. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114:S155-212.
3. Hamilos DL. Chronic sinusitis. J Allergy Clin Immunol 2000;106:213-26.
4. Ochs HD, Winkelstein J. Disorders of the B cell system. In: Stiehm RE, editor. Immunologic disorders in infants and children. Philadelphia: WB.Saunders, 1996:296-338.
5. Bent JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994;111:580-8.
6. Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol 1977;59:17-21.
7. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophillic inflammation. J Allergy Clin Immunol 2001;107:607-14
8. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996;17:231-6.
9. Eichel BS. A proposal for a staging system for hyperplastic rhinosinusitis based on the presence or absence of intranasal polyposis. Ear Nose Throat J 1999;78:262-5.
10. Morell A, Skvaril F, Steinberg AG, Van Loghem E, Terry WD. Correlations between the concentrations of the four subclasses of IgG and GM allotypes of normal human sera. J Immunol 1972;108:195-206.
11. Pan Q, Hammarstrom L. Molecular basis of IgG subclass deficiency. Immunol Rev 2000;178:99-110.
12. Oxelius VA, Hanson LA, Bjorkander T, Oxelius VA, Hanson LA, Bjorkander J, et al. IgG3 deficiency: common in obstructive lung disease. In : Hanson LA, Solderstrom T, Oxelius VA, editors. Immunoglobulin subclass deficiencies. Basel: Karger, 1986:106-15.
13. Linde A, Soderstrom R, Smith CI, Linde A, Soderstrom R, Smith CI, et al. Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3. Clin Exp Immunol 1992;90:199-203.
14. Hammarstrom L, Smith CIE. IgG2 deficiency in a healthy blood donor concomitant lack of IgG2, IgA and IgE immunoglobulins and specific anti-carbohydrate antibodies. Clin Exp Immunol 1983;51:600-4.
15. Vichyanond P, Petraratt S, Assateerawatt A, Senawongse S, Tuchinda M. IgG subclass levels in Thai children, both normal and those with frequent respiratory tract infections. Thai J Pediatr 1996;35:233-8.
16. Hartwig S, Linden M, Laurent C, Vargo AK, Lindqvist N. Budesonide nasal spray as prophylactic treatment after polypectomy (a double-blind clinical trial). J Laryngol Otol 1988;102:148-51.
17. Karlsson G, Rundcrantz H. A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 1982;20:144-8.
18. Virolainen E, Puhakka H. The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy. Rhinology 1980;18:9-18.
19. Krouse HA, Phung ND, Klaustermeyer WB. Intranasal beclomethasone in severe rhinosinusitis and nasal polyps. Ann Allergy 1983;50:385-8.
20. Van Camp C, Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology 1994;32:5-9.
21. Stammberger H. Surgical treatment of nasal polyps: past, present, and future. Allergy 1999;54:7-11.
22. Mygind N, Lildholdt T. Nasal polyps treatment: medical management. Allergy Asthma Proc 1996;17:275-82.
23. Lanza DE, Kennedy DW. Current concepts in the surgical management of nasal polyposis. J Allergy Clin Immunol 1992;90:543-5.
24. Herrod HG. Management of the patient with IgG subclass deficiency and/or selective antibody deficiency. Ann Allergy 1993;70:3-8.
25. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? Trends Pharmacol Sci 2004;25:306-10.
26. Bayry J, Misra N, Latry V,Bayry J, Misra N, Latry V, et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Transfus Clin Biol 2003;10:165-9.